866-997-4948(US-Canada Toll Free)

Global Immuno-oncology Therapy Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 114 Pages

This report studies the global market size of Immuno-oncology Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Immuno-oncology Therapy in these regions.
This research report categorizes the global Immuno-oncology Therapy market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Cancer immunotherapy(sometimes called immuno-oncology) is the use of theimmune systemto treatcancer.
In 2017, the global Immuno-oncology Therapy market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Immuno-oncology Therapy market based on company, product type, application and key regions.

The various contributors involved in the value chain of Immuno-oncology Therapy include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Immuno-oncology Therapy include
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda

Market Size Split by Type
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
Market Size Split by Application
Hospitals
Ambulatory Surgical Center
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Immuno-oncology Therapy market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Immuno-oncology Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Immuno-oncology Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Immuno-oncology Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Immuno-oncology Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Immuno-oncology Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Immuno-oncology Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Immuno-oncology Therapy Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Immune Checkpoint Inhibitors
1.4.4 Immune System Modulators
1.4.5 Cancer Vaccines
1.4.6 Others
1.5 Market by Application
1.5.1 Global Immuno-oncology Therapy Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Center
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Immuno-oncology Therapy Market Size
2.1.1 Global Immuno-oncology Therapy Revenue 2016-2025
2.1.2 Global Immuno-oncology Therapy Sales 2016-2025
2.2 Immuno-oncology Therapy Growth Rate by Regions
2.2.1 Global Immuno-oncology Therapy Sales by Regions
2.2.2 Global Immuno-oncology Therapy Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Immuno-oncology Therapy Sales by Manufacturers
3.1.1 Immuno-oncology Therapy Sales by Manufacturers
3.1.2 Immuno-oncology Therapy Sales Market Share by Manufacturers
3.1.3 Global Immuno-oncology Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Immuno-oncology Therapy Revenue by Manufacturers
3.2.1 Immuno-oncology Therapy Revenue by Manufacturers (2016-2018)
3.2.2 Immuno-oncology Therapy Revenue Share by Manufacturers (2016-2018)
3.3 Immuno-oncology Therapy Price by Manufacturers
3.4 Immuno-oncology Therapy Manufacturing Base Distribution, Product Types
3.4.1 Immuno-oncology Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immuno-oncology Therapy Product Category
3.4.3 Date of International Manufacturers Enter into Immuno-oncology Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Immuno-oncology Therapy Sales by Type
4.2 Global Immuno-oncology Therapy Revenue by Type
4.3 Immuno-oncology Therapy Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Immuno-oncology Therapy Breakdown Data by Application

6 North America
6.1 North America Immuno-oncology Therapy by Countries
6.1.1 North America Immuno-oncology Therapy Sales by Countries
6.1.2 North America Immuno-oncology Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Immuno-oncology Therapy by Type
6.3 North America Immuno-oncology Therapy by Application
6.4 North America Immuno-oncology Therapy by Company

7 Europe
7.1 Europe Immuno-oncology Therapy by Countries
7.1.1 Europe Immuno-oncology Therapy Sales by Countries
7.1.2 Europe Immuno-oncology Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immuno-oncology Therapy by Type
7.3 Europe Immuno-oncology Therapy by Application
7.4 Europe Immuno-oncology Therapy by Company

8 Asia Pacific
8.1 Asia Pacific Immuno-oncology Therapy by Countries
8.1.1 Asia Pacific Immuno-oncology Therapy Sales by Countries
8.1.2 Asia Pacific Immuno-oncology Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Immuno-oncology Therapy by Type
8.3 Asia Pacific Immuno-oncology Therapy by Application
8.4 Asia Pacific Immuno-oncology Therapy by Company

9 Central & South America
9.1 Central & South America Immuno-oncology Therapy by Countries
9.1.1 Central & South America Immuno-oncology Therapy Sales by Countries
9.1.2 Central & South America Immuno-oncology Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Immuno-oncology Therapy by Type
9.3 Central & South America Immuno-oncology Therapy by Application
9.4 Central & South America Immuno-oncology Therapy by Company

10 Middle East and Africa
10.1 Middle East and Africa Immuno-oncology Therapy by Countries
10.1.1 Middle East and Africa Immuno-oncology Therapy Sales by Countries
10.1.2 Middle East and Africa Immuno-oncology Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Immuno-oncology Therapy by Type
10.3 Middle East and Africa Immuno-oncology Therapy by Application
10.4 Middle East and Africa Immuno-oncology Therapy by Company

11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.1.4 Immuno-oncology Therapy Product Description
11.1.5 Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.2.4 Immuno-oncology Therapy Product Description
11.2.5 Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.3.4 Immuno-oncology Therapy Product Description
11.3.5 Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.4.4 Immuno-oncology Therapy Product Description
11.4.5 Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.5.4 Immuno-oncology Therapy Product Description
11.5.5 Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.6.4 Immuno-oncology Therapy Product Description
11.6.5 Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.7.4 Immuno-oncology Therapy Product Description
11.7.5 Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.8.4 Immuno-oncology Therapy Product Description
11.8.5 Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.9.4 Immuno-oncology Therapy Product Description
11.9.5 Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.10.4 Immuno-oncology Therapy Product Description
11.10.5 Recent Development
11.11 Sanofi
11.12 Spectrum Pharmaceuticals
11.13 Takeda

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Immuno-oncology Therapy Raw Material
13.1.2 Immuno-oncology Therapy Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Immuno-oncology Therapy
Figure Global Immuno-oncology Therapy Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Immuno-oncology Therapy Production Market Share by Types (Product Category) in 2017
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Immune Checkpoint Inhibitors Product Picture
Table Major Manufacturers of Immune Checkpoint Inhibitors
Figure Immune System Modulators Product Picture
Table Major Manufacturers of Immune System Modulators
Figure Cancer Vaccines Product Picture
Table Major Manufacturers of Cancer Vaccines
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Immuno-oncology Therapy Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospitals
Figure Ambulatory Surgical Center
Figure Others
Figure Immuno-oncology Therapy Report Years Considered
Figure Global Immuno-oncology Therapy Market Size 2016-2025 (Million US$)
Figure Global Immuno-oncology Therapy Sales 2016-2025 (K Units)
Table Global Immuno-oncology Therapy Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Immuno-oncology Therapy Sales by Regions 2016-2025 (K Units)
Table Global Immuno-oncology Therapy Sales Market Share by Regions 2016-2025
Figure Global Immuno-oncology Therapy Sales Market Share by Regions 2016-2025
Figure 2017 Global Immuno-oncology Therapy Sales Market Share by Regions
Table Global Immuno-oncology Therapy Revenue by Regions 2016-2025 (Million US$)
Table Global Immuno-oncology Therapy Revenue Market Share by Regions 2016-2025
Figure Global Immuno-oncology Therapy Revenue Market Share by Regions 2016-2025
Figure 2017 Global Immuno-oncology Therapy Revenue Market Share by Regions
Table Global Immuno-oncology Therapy Sales by Manufacturers (2016-2018) (K Units)
Table Global Immuno-oncology Therapy Sales Share by Manufacturers (2016-2018)
Figure Global Immuno-oncology Therapy Sales Share by Manufacturers in 2017
Table Immuno-oncology Therapy Revenue by Manufacturers (2016-2018) (Million US$)
Table Immuno-oncology Therapy Revenue Share by Manufacturers (2016-2018)
Figure Immuno-oncology Therapy Value Share by Manufacturers in 2017
Table Global Immuno-oncology Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Immuno-oncology Therapy Price (2016-2018) (USD/Unit)
Table Immuno-oncology Therapy Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Immuno-oncology Therapy Product Category
Table Date of International Manufacturers Enter into Immuno-oncology Therapy Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Immuno-oncology Therapy Sales by Type (2016-2025) (K Units)
Table Global Immuno-oncology Therapy Sales Share by Type (2016-2025)
Figure Global Immuno-oncology Therapy Sales Market Share by Type (2016-2025)
Figure Global Immuno-oncology Therapy Sales Market Share by Type in 2017
Table Global Immuno-oncology Therapy Revenue by Type (2016-2025) (Million US$)
Table Global Immuno-oncology Therapy Revenue Share by Type (2016-2025)
Figure Global Immuno-oncology Therapy Revenue Market Share by Type (2016-2025)
Figure Global Immuno-oncology Therapy Revenue Market Share by Type in 2017
Table Immuno-oncology Therapy Price by Type 2013-2018 (USD/Unit)
Table Global Immuno-oncology Therapy Sales by Application (2016-2025) (K Units)
Table Global Immuno-oncology Therapy Sales Share by Application (2016-2025)
Figure Global Sales Immuno-oncology Therapy Market Share by Application (2016-2025)
Figure Global Sales Immuno-oncology Therapy Market Share by Application (2016-2025)
Figure North America Immuno-oncology Therapy Sales Growth Rate 2016-2025 (K Units)
Figure North America Immuno-oncology Therapy Revenue Growth Rate 2016-2025 (Million US$)
Table North America Immuno-oncology Therapy Sales by Countries (2016-2025) (K Units)
Table North America Immuno-oncology Therapy Sales Market Share by Countries (2016-2025)
Figure 2017 North America Immuno-oncology Therapy Sales Market Share by Countries
Table North America Immuno-oncology Therapy Revenue by Countries (2016-2025) (Million US$)
Table North America Immuno-oncology Therapy Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Immuno-oncology Therapy Revenue Market Share by Countries
Figure United States Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure United States Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Canada Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Table North America Immuno-oncology Therapy Sales by Type (2016-2025) (K Units)
Table North America Immuno-oncology Therapy Sales Market Share by Type (2016-2025)
Figure 2017 North America Immuno-oncology Therapy Market Share by Type
Table North America Immuno-oncology Therapy Sales by Application (2016-2025) (K Units)
Table North America Immuno-oncology Therapy Sales Market Share by Application (2016-2025)
Figure 2017 North America Immuno-oncology Therapy Market Share by Application
Table North America Immuno-oncology Therapy Sales by Company (2016-2018) (K Units)
Table North America Immuno-oncology Therapy Sales Market Share by Company (2016-2018)
Figure North America Immuno-oncology Therapy Sales Market Share by Company in 2017
Figure Europe Immuno-oncology Therapy Sales Growth Rate 2016-2025 (K Units)
Figure Europe Immuno-oncology Therapy Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Immuno-oncology Therapy Sales by Countries (2016-2025) (K Units)
Table Europe Immuno-oncology Therapy Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Immuno-oncology Therapy Sales Market Share by Countries
Table Europe Immuno-oncology Therapy Revenue by Countries (2016-2025) (Million US$)
Table Europe Immuno-oncology Therapy Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Immuno-oncology Therapy Revenue Market Share by Countries
Figure Germany Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Germany Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (K Units)
Figure France Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure France Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (K Units)
Figure UK Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure UK Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Italy Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Russia Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Immuno-oncology Therapy Sales by Type (2016-2025) (K Units)
Table Europe Immuno-oncology Therapy Sales Market Share by Type (2016-2025)
Figure 2017 Europe Immuno-oncology Therapy Market Share by Type
Table Europe Immuno-oncology Therapy Sales by Application (2016-2025) (K Units)
Table Europe Immuno-oncology Therapy Sales Market Share by Application (2016-2025)
Figure 2017 Europe Immuno-oncology Therapy Market Share by Application
Table Europe Immuno-oncology Therapy Sales by Company (2016-2018) (K Units)
Table Europe Immuno-oncology Therapy Sales Market Share by Company (2016-2018)
Figure Europe Immuno-oncology Therapy Sales Market Share by Company in 2017
Figure Asia Pacific Immuno-oncology Therapy Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Immuno-oncology Therapy Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Immuno-oncology Therapy Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Immuno-oncology Therapy Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Immuno-oncology Therapy Sales Market Share by Countries
Table Asia Pacific Immuno-oncology Therapy Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Immuno-oncology Therapy Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Immuno-oncology Therapy Revenue Market Share by Countries
Figure China Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure China Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Japan Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Korea Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure India Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure India Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Australia Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Immuno-oncology Therapy Sales by Type (2016-2025) (K Units)
Table Asia Pacific Immuno-oncology Therapy Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Immuno-oncology Therapy Market Share by Type
Table Asia Pacific Immuno-oncology Therapy Sales by Application (2016-2025) (K Units)
Table Asia Pacific Immuno-oncology Therapy Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Immuno-oncology Therapy Market Share by Application
Table Asia Pacific Immuno-oncology Therapy Sales by Company (2016-2018) (K Units)
Table Asia Pacific Immuno-oncology Therapy Sales Market Share by Company (2016-2018)
Figure Asia Pacific Immuno-oncology Therapy Sales Market Share by Company in 2017
Figure Central & South America Immuno-oncology Therapy Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Immuno-oncology Therapy Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Immuno-oncology Therapy Sales by Countries (2016-2025) (K Units)
Table Central & South America Immuno-oncology Therapy Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Immuno-oncology Therapy Sales Market Share by Countries
Table Central & South America Immuno-oncology Therapy Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Immuno-oncology Therapy Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Immuno-oncology Therapy Revenue Market Share by Countries
Figure Brazil Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Immuno-oncology Therapy Sales by Type (2016-2025) (K Units)
Table Central & South America Immuno-oncology Therapy Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Immuno-oncology Therapy Market Share by Type
Table Central & South America Immuno-oncology Therapy Sales by Application (2016-2025) (K Units)
Table Central & South America Immuno-oncology Therapy Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Immuno-oncology Therapy Market Share by Application
Table Central & South America Immuno-oncology Therapy Sales by Company (2016-2018) (K Units)
Table Central & South America Immuno-oncology Therapy Sales Market Share by Company (2016-2018)
Figure Central & South America Immuno-oncology Therapy Sales Market Share by Company in 2017
Figure Middle East and Africa Immuno-oncology Therapy Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Immuno-oncology Therapy Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Immuno-oncology Therapy Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Immuno-oncology Therapy Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Immuno-oncology Therapy Sales Market Share by Countries
Table Middle East and Africa Immuno-oncology Therapy Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Immuno-oncology Therapy Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Immuno-oncology Therapy Revenue Market Share by Countries
Figure GCC Countries Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Immuno-oncology Therapy Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Immuno-oncology Therapy Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Immuno-oncology Therapy Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Immuno-oncology Therapy Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Immuno-oncology Therapy Market Share by Type
Table Middle East and Africa Immuno-oncology Therapy Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Immuno-oncology Therapy Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Immuno-oncology Therapy Market Share by Application
Table Middle East and Africa Immuno-oncology Therapy Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Immuno-oncology Therapy Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Immuno-oncology Therapy Sales Market Share by Company in 2017
Table Amgen Company Details
Table Amgen Immuno-oncology Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Immuno-oncology Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Immuno-oncology Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bristol-Myers Squibb Recent Development
Table Eli-Lilly Company Details
Table Eli-Lilly Immuno-oncology Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Eli-Lilly Recent Development
Table Roche Company Details
Table Roche Immuno-oncology Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Roche Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Immuno-oncology Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Janssen Biotech Company Details
Table Janssen Biotech Immuno-oncology Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Janssen Biotech Recent Development
Table Merck Company Details
Table Merck Immuno-oncology Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Immuno-oncology Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Immuno-oncology Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Spectrum Pharmaceuticals Company Details
Table Takeda Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Immuno-oncology Therapy Value Chain
Table Typical Suppliers of Key Immuno-oncology Therapy Raw Material
Table Immuno-oncology Therapy Customers List
Table Immuno-oncology Therapy Sales Channels
Table Immuno-oncology Therapy Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *